Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.
第一作者:
Lorenzo M,Canziani
第一单位:
Humanitas University, Department of Biomedical Sciences, Pieve Emanuele (MI), Italy; Internal Medicine, Humanitas Gavazzeni, Bergamo (BG), Italy.
作者:
医学主题词
老年人(Aged);病例对照研究(Case-Control Studies);冠状病毒感染(Coronavirus Infections);女(雌)性(Female);医院死亡率(Hospital Mortality);人类(Humans);输注, 静脉内(Infusions, Intravenous);白细胞介素6(Interleukin-6);男(雄)性(Male);中年人(Middle Aged);疾病大流行(Pandemics);肺炎, 病毒性(Pneumonia, Viral);受体, 白细胞介素6(Receptors, Interleukin-6);回顾性研究(Retrospective Studies);疾病严重程度指数(Severity of Illness Index);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)
DOI
10.1016/j.jaut.2020.102511
PMID
32713677
发布时间
2024-08-01
- 浏览0
Journal of autoimmunity
102511页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



